OPTIMI HEALTH CORP. (8BN) - Total Assets

Latest as of December 2025: €14.24 Million EUR ≈ $16.64 Million USD

Based on the latest financial reports, OPTIMI HEALTH CORP. (8BN) holds total assets worth €14.24 Million EUR (≈ $16.64 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of OPTIMI HEALTH CORP. for net asset value and shareholders' equity analysis.

OPTIMI HEALTH CORP. - Total Assets Trend (2022–2025)

This chart illustrates how OPTIMI HEALTH CORP.'s total assets have evolved over time, based on quarterly financial data.

OPTIMI HEALTH CORP. - Asset Composition Analysis

Current Asset Composition (September 2025)

OPTIMI HEALTH CORP.'s total assets of €14.24 Million consist of 12.0% current assets and 88.0% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 7.5%
Accounts Receivable €95.05K 0.6%
Inventory €310.39K 2.0%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €0.00 0.0%
Goodwill €0.00 0.0%

Asset Composition Trend (2022–2025)

This chart illustrates how OPTIMI HEALTH CORP.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 8BN stock market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: OPTIMI HEALTH CORP.'s current assets represent 12.0% of total assets in 2025, a decrease from 14.4% in 2022.
  • Cash Position: Cash and equivalents constituted 7.5% of total assets in 2025, down from 11.2% in 2022.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
  • Asset Diversification: The largest asset category is inventory at 2.0% of total assets.

OPTIMI HEALTH CORP. Competitors by Total Assets

Key competitors of OPTIMI HEALTH CORP. based on total assets are shown below.

Company Country Total Assets
Yabao Pharmaceutical Group Co Ltd
SHG:600351
China CN¥3.34 Billion
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
China CN¥68.33 Billion
Sandoz Group AG
SW:SDZ
Switzerland CHF21.61 Billion
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Sweden Skr67.43 Billion
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Germany €1.60 Trillion
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
China CN¥14.22 Billion
Kangmei Pharmaceutical Co Ltd
SHG:600518
China CN¥13.68 Billion
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
China CN¥19.57 Billion

OPTIMI HEALTH CORP. - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.12 0.25 0.38
Quick Ratio 0.09 0.08 0.11
Cash Ratio 0.00 0.00 0.00
Working Capital €-7.96 Million €-2.67 Million €-1.98 Million

OPTIMI HEALTH CORP. - Advanced Valuation Insights

This section examines the relationship between OPTIMI HEALTH CORP.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.21
Latest Market Cap to Assets Ratio 1.18
Asset Growth Rate (YoY) 4.5%
Total Assets €15.21 Million
Market Capitalization $17.99 Million USD

Valuation Analysis

Above Book Valuation: The market values OPTIMI HEALTH CORP.'s assets above their book value (1.18x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: OPTIMI HEALTH CORP.'s assets grew by 4.5% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for OPTIMI HEALTH CORP. (2022–2025)

The table below shows the annual total assets of OPTIMI HEALTH CORP. from 2022 to 2025.

Year Total Assets Change
2025-09-30 €15.21 Million
≈ $17.79 Million
+4.55%
2024-09-30 €14.55 Million
≈ $17.01 Million
-11.77%
2023-09-30 €16.49 Million
≈ $19.28 Million
-1.94%
2022-09-30 €16.82 Million
≈ $19.66 Million
--

About OPTIMI HEALTH CORP.

F:8BN Germany Drug Manufacturers - Specialty & Generic
Market Cap
$23.08 Million
€19.74 Million EUR
Market Cap Rank
#25359 Global
#2190 in Germany
Share Price
€0.20
Change (1 day)
-3.77%
52-Week Range
€0.08 - €0.26
All Time High
€0.58
About

Optimi Health Corp. operates as a GMP-certified pharmaceutical drug manufacturing company in Canada. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company offers raw mushroom biomass, mushroom extracts, and mushroom supplements, as well as a range of m… Read more